Arctic Bioscience Insider Buys 10,000 Shares

Arctic Bioscience AS (DE:9TD) has released an update.

Nils Erik Bjørkedal, closely associated with Arctic Bioscience’s Quality Manager, has acquired 10,000 shares of the company at an average of NOK 10.42 each. This purchase increases his total holdings to 10,000 shares in the biotech firm. Arctic Bioscience specializes in developing pharmaceuticals and nutraceuticals derived from marine bioactive compounds, with a focus on a new psoriasis treatment.

For further insights into DE:9TD stock, check out TipRanks’ Stock Analysis page.